Belotero Balance® (+) | Home
BELOTERO BALANCE is a prescription injection that is approved to temporarily smooth out and fill in moderate to severe nasolabial folds (the folds or wrinkles that go from the side of the …
Belotero Balance® (+) | Treatment Areas - Patient
Belotero Balance (+) dermal fillers treats many areas of the lower face and under the eyes. See Important Safety Information.
Belotero Balance® (+) | FAQs
BELOTERO BALANCE is a prescription injection that is approved to temporarily smooth out and fill in moderate to severe nasolabial folds (the folds or wrinkles that go from the side of the …
Before & After - Belotero BALANCE
What is BELOTERO BALANCE® (+)? BELOTERO BALANCE is a prescription injection that is approved to temporarily smooth out and fill in moderate to severe nasolabial folds (the folds or …
Find a Provider - Belotero BALANCE
BELOTERO BALANCE is a prescription injection that is approved to temporarily smooth out and fill in moderate to severe nasolabial folds (the folds or wrinkles that go from the side of the …
BELOTERO BALANCE® (+) Injectable Implant is FDA-approved for injection into the mid-to-deep dermis for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial …
Belotero Balance® (+) | HCP Site
BELOTERO BALANCE® (+) Injectable Implant is FDA-approved for injection into the mid-to-deep dermis for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial …
Belotero Balance® (+) is a clear, hyaluronic acid gel and a small quantity of an anaesthetic (lidocaine) to reduce the sensation of pain, and the chemical BDDE to make it last longer.
Treatment Areas - Belotero Balance® (+) HCP
BELOTERO BALANCE® (+) Injectable Implant is FDA-approved for injection into the mid-to-deep dermis for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial …
Clinical Data & MOA | Belotero Balance® (+) HCP
See clinical data and MOA information on Belotero Balance (+) a hyalauronic acid filler. See Important Safety Information.